title: A multi-head intradermal electroporation device allows for tailored and increased dose DNA vaccine delivery to the skin.
abstract: The identification of an effective and tolerable delivery method is a necessity for the success of DNA vaccines in the clinic. This article describes the development and validation of a multi-headed intradermal electroporation device which would be applicable for delivering multiple DNA vaccine plasmids simultaneously but spatially separated. Reporter gene plasmids expressing green and red fluorescent proteins were used to demonstrate the impact of spatial separation on DNA delivery to increase the number of transfected cells and avoid interference through visible expression patterns. To investigate the impact of plasmid interference on immunogenicity, a disease target was investigated where issues with multi-valent vaccines had been previously described. DNA-based Hantaan and Puumala virus vaccines were delivered separately or as a combination and the effect of multi-valence was determined by appropriate assays. While a negative impact was observed for both antigenic vaccines when delivered together, these effects were mitigated when the vaccine was delivered using the multi-head device. We also demonstrate how the multi-head device facilitates higher dose delivery to the skin resulting in improved immune responses. This new multi-head platform device is an efficient, tolerable and non-invasive method to deliver multiple plasmid DNA constructs simultaneously allowing the tailoring of delivery sites for combination vaccines. Additionally, this device would allow the delivery of multi-plasmid vaccine formulations without risk of impacted immune responses through interference. Such a low-cost, easy to use device platform for the delivery of multi-agent DNA vaccines would have direct applications by the military and healthcare sectors for mass vaccination purposes.
authors.affiliation: a Inovio Pharmaceuticals Inc. ; Blue Bell , PA USA.
authors.forename: Jay R
authors.initials: JR
authors.lastname: McCoy
authors.forename: Janess M
authors.initials: JM
authors.lastname: Mendoza
authors.forename: Kristin W
authors.initials: KW
authors.lastname: Spik
authors.forename: Catherine
authors.initials: C
authors.lastname: Badger
authors.forename: Alan F
authors.initials: AF
authors.lastname: Gomez
authors.forename: Connie S
authors.initials: CS
authors.lastname: Schmaljohn
authors.forename: Niranjan Y
authors.initials: NY
authors.lastname: Sardesai
authors.forename: Kate E
authors.initials: KE
authors.lastname: Broderick
mesh_terms: D000818:Animals; D018274:Electroporation / Q000295:instrumentation* / Q000379:methods*; D005260:Female; D006168:Guinea Pigs; D018063:Hantaan virus / Q000235:genetics / Q000276:immunology; D007271:Injections, Intradermal; D008647:Mesocricetus; D010957:Plasmids / Q000008:administration & dosage; D029262:Puumala virus / Q000235:genetics / Q000276:immunology; D019444:Vaccines, DNA / Q000008:administration & dosage* / Q000276:immunology; D014765:Viral Vaccines / Q000008:administration & dosage* / Q000276:immunology
chemical_list: D019444:Vaccines, DNA; D014765:Viral Vaccines
keywords: DNA vaccine; dermal; electroporation; multi-agent; noninvasive; tolerable
references.citation: J Infect Dis. 2013 Sep 1;208(5):818-29
references.pmid: 23840043
references.citation: Hum Gene Ther Methods. 2012 Jun;23(3):157-68
references.pmid: 22794496
references.citation: Virology. 2006 Mar 30;347(1):208-16
references.pmid: 16378630
references.citation: Vaccine. 2006 Mar 15;24(12):2200-7
references.pmid: 16316713
references.citation: Genet Vaccines Ther. 2012 Aug 08;10(1):5
references.pmid: 22873174
references.citation: Mol Ther Nucleic Acids. 2012 Feb 14;1:e11
references.pmid: 23344722
references.citation: J Infect Dis. 2001 Oct 1;184(7):809-16
references.pmid: 11550123
references.citation: Virology. 2001 May 25;284(1):46-61
references.pmid: 11352667
references.citation: Vaccines (Basel). 2013 Aug 22;1(3):367-83
references.pmid: 26344119
references.citation: Biophys Chem. 1984 May;19(3):211-25
references.pmid: 6722274
references.citation: Curr Opin Immunol. 2011 Jun;23(3):421-9
references.pmid: 21530212
references.citation: Biophys Chem. 1987 May 9;26(2-3):321-35
references.pmid: 3607233
references.citation: PLoS One. 2012;7(4):e34723
references.pmid: 22509350
references.citation: J Virol. 2001 Nov;75(22):10991-1001
references.pmid: 11602739
references.citation: J Immunol. 2000 May 1;164(9):4635-40
references.pmid: 10779767
references.citation: Virology. 2003 Sep 15;314(1):134-46
references.pmid: 14517067
references.citation: Gene Ther. 2007 Apr;14(7):553-64
references.pmid: 17215847
references.citation: Vaccine. 2010 Feb 23;28(8):2046-52
references.pmid: 19896448
references.citation: Gene Ther. 2011 Mar;18(3):258-65
references.pmid: 20962869
references.citation: Vaccine. 2008 Sep 19;26(40):5073-4
references.pmid: 18652867
references.citation: Vaccine. 2004 Jun 23;22(19):2489-93
references.pmid: 15193413
references.citation: Vaccine. 2012 Nov 6;30(48):6946-54
references.pmid: 22406460
references.citation: Vaccine. 2010 Nov 29;28(51):8203-9
references.pmid: 20951666
references.citation: PLoS One. 2012;7(9):e45146
references.pmid: 23024803
references.citation: Biochem Biophys Res Commun. 2001 Mar 30;282(2):442-6
references.pmid: 11401479
references.citation: PLoS One. 2013;8(5):e62720
references.pmid: 23667513
references.citation: J Infect Dis. 2011 Jan 1;203(1):95-102
references.pmid: 21148501
references.citation: Vaccines (Basel). 2013 Aug 28;1(3):384-97
references.pmid: 26344120
references.citation: PLoS One. 2008;3(6):e2517
references.pmid: 18575608
references.citation: Gene Ther. 1999 Apr;6(4):508-14
references.pmid: 10476210
references.citation: Mol Ther. 2012 Jan;20(1):214-20
references.pmid: 22068424
references.citation: Hum Vaccin Immunother. 2012 Nov 1;8(11):1694-702
references.pmid: 23111168
references.citation: J Virol. 1998 Feb;72(2):1497-503
references.pmid: 9445053
references.citation: Virology. 2000 Jan 20;266(2):329-39
references.pmid: 10639319
references.citation: Vaccine. 2006 May 22;24(21):4503-9
references.pmid: 16181711
references.citation: Mol Ther. 2005 Dec;12(6):1197-205
references.pmid: 16112909
references.citation: Vaccine. 2008 Sep 19;26(40):5177-81
references.pmid: 18482782
references.citation: Sci Transl Med. 2012 Oct 10;4(155):155ra138
references.pmid: 23052295
references.citation: PLoS One. 2011;6(4):e19181
references.pmid: 21559474
references.citation: Vaccine. 2007 Jun 6;25(23):4540-53
references.pmid: 17485151
references.citation: Vaccine. 2013 Aug 20;31(37):3843-8
references.pmid: 23831327